Associate Professor Ryan Demmer is co-leading the study with the School of Nursing to help healthcare systems determine how to best support the health and well-being of employees during the COVID-19 crisis. (Ryan Demmer)
Research by PhD student Zachary Levin showed that some states have seen COVID-19 pediatric hospitalizations increase by as much as 5,000%. (Zachary Levin)
PhD student Madhura Vachon found that direct farm animal contact was a key risk factor for the development of hemolytic uremic syndrome among people infected with Shiga toxin-producing E. coli.
The tool developed by Associate Professor Eva Enns uses key data, such as group size, to predict how many new infections and hospitalizations gatherings could trigger in the state.
Professor Craig Hedberg is recruiting 1,000 Minnesota grocery store workers for a study to see if they have antibodies for the virus causing COVID-19.
Professor Joseph Koopmeiners explains how the typical three-phase clinical trial works and the ways researchers and the FDA are safely speeding up the development of COVID-19 vaccines.
Professor Jim Neaton and the school’s Coordinating Centers for Biometric Research are running a trial to test a COVID-19 treatment that combines a highly concentrated solution of antibodies with the drug remdesivir.
PhD student Austin Rau analyzed the cases of three serious — but lesser-known — tick-borne diseases in Wisconsin and found that they are increasing, moving, and varying over time across the state.
The results of the study led by Associate Professor Ryan Demmer suggest that the prevalence of active infection at any single point in time is potentially low among health care workers without symptoms.
Professor Shalini Kulasingam is leading a survey of Minnesotans to learn about their daily social contact patterns during the outbreak. The data from the study will be incorporated into one of the models used by the State to plan its response to the pandemic.
The pollution study by Assistant Professor Jesse Berman showed that nitrogen dioxide and fine particulate matter levels in the U.S. dropped during March and April compared to the same months in previous years.
A study by researchers Stuart Grande and Jude Mikal shows that giving HIV patients choices and support are the keys to ensuring they complete treatment to prevent tuberculosis.